 PASADENA, CA, March 16, 2022 GLOBE NEWSWIRE -- LIXTE Biotechnology Holdings, Inc. Nasdaq: LIXT, a clinical-stage drug discovery company developing pharmacologically active drugs for use in cancer treatment, will present at the MedInvest Pharmaceutical and Biotechnology Investor Conference to be held March 28 - April 1, 2022. Lixtes presentation will take place on Thursday, March 31 at 12:00 - 12:20pm EDT. 